Cargando…

Reduction in Preterm Preeclampsia after Contingent First-Trimester Screening and Aspirin Prophylaxis in a Routine Care Setting

Objectives: Several multivariate algorithms for preeclampsia (PE) screening in the first trimester have been developed over the past few years. These models include maternal factors, mean arterial pressure (MAP), uterine artery Doppler (UtA-PI), and biochemical markers (pregnancy-associated plasma p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trilla, Cristina, Mora, Josefina, Ginjaume, Nuria, Nan, Madalina Nicoleta, Alejos, Obdulia, Domínguez, Carla, Vega, Carmen, Godínez, Yessenia, Cruz-Lemini, Monica, Parra, Juan, Llurba, Elisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406877/ https://www.ncbi.nlm.nih.gov/pubmed/36010165 http://dx.doi.org/10.3390/diagnostics12081814

Ejemplares similares

Impact of Angiogenic and Cardiovascular Biomarkers for Prediction of Placental Dysfunction in the First Trimester of Pregnancy
por: Nan, Madalina Nicoleta, et al.
Publicado: (2023)

Screening for Preeclampsia in the First Trimester and Aspirin Prophylaxis: Our First Year
por: Lourenço, Inês, et al.
Publicado: (2020)

Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers
por: Garrido-Giménez, Carmen, et al.
Publicado: (2023)

Longitudinal Behavior of Left-Ventricular Strain in Fetal Growth Restriction
por: Domínguez-Gallardo, Carla, et al.
Publicado: (2023)

First-Trimester Sequential Screening for Preeclampsia Using Angiogenic Factors: Study Protocol for a Prospective, Multicenter, Real Clinical Setting Study
por: Trilla, Cristina, et al.
Publicado: (2022)

Cardiac dysfunction and remodeling regulated by anti-angiogenic environment in patients with preeclampsia: the ANGIOCOR prospective cohort study protocol
por: Ullmo, Johana, et al.
Publicado: (2021)

Is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?
por: Hantoushzadeh, Sedigheh, et al.
Publicado: (2022)

Preeclampsia and aspirin
por: Ahn, Tae Gyu, et al.
Publicado: (2023)

Aspirin for Prevention of Preeclampsia
por: Atallah, A., et al.
Publicado: (2017)

Aspirin for Prevention of Preeclampsia in Lupus Pregnancy
por: Schramm, Amelie M., et al.
Publicado: (2014)

Missed opportunities in aspirin prescribing for preeclampsia prevention
por: Singh, Noreen, et al.
Publicado: (2023)

Evaluation of first- and third-trimester afamin levels in preeclampsia
por: Gülücü, Selim, et al.
Publicado: (2023)

The Aspirin Foundation Scientific Conference: the history, the present state and the future of aspirin prophylaxis
por: Smith, Tom, et al.
Publicado: (2014)

Shared risk factors for COVID‐19 and preeclampsia in the first trimester: An observational study
por: Serrano, Berta, et al.
Publicado: (2022)

A new contingent screening strategy increased detection rate of trisomy 21 in the first trimester
por: Luo, Wei, et al.
Publicado: (2023)

Gut microbiota dysbiosis in preeclampsia patients in the second and third trimesters
por: Wang, Jing, et al.
Publicado: (2020)

Non-Coding RNAs and Prediction of Preeclampsia in the First Trimester of Pregnancy
por: Ogoyama, Manabu, et al.
Publicado: (2022)

Is the First-Trimester Systemic Immune-Inflammation Index Associated With Preeclampsia?
por: Cevher Akdulum, Munire Funda, et al.
Publicado: (2023)

Aspirin Prophylaxis for the Prevention of Thrombosis: Expectations and Limitations
por: Rao, Gundu H. R., et al.
Publicado: (2012)

“Abnormal Analyte Preeclampsia”: Do the second trimester maternal serum analytes help differentiate preeclampsia subtypes?
por: CRITCHFIELD, Agatha S, et al.
Publicado: (2013)

Screening for preeclampsia risk and prophylaxis with acetylsalicylic acid
por: Jain, Venu, et al.
Publicado: (2023)

Adiposity and hyperleptinemia during the first trimester among pregnant women with preeclampsia
por: Yeboah, Francis Agyemang, et al.
Publicado: (2017)

Integrating Combined First Trimester Screening for Preeclampsia into Routine Ultrasound Examination
por: Trottmann, Fabienne, et al.
Publicado: (2022)

Results of a Five-Year Experience in First Trimester Preeclampsia Screening
por: Capriglione, Stella, et al.
Publicado: (2022)

Effects of maternal characteristics and medical history on first trimester biomarkers for preeclampsia
por: Torres-Torres, Johnatan, et al.
Publicado: (2023)

First-trimester preeclampsia screening and prevention: impact on patient satisfaction and anxiety
por: Silang, Katherine, et al.
Publicado: (2023)

Identification of novel first-trimester serum biomarkers for early prediction of preeclampsia
por: Liu, Mingxi, et al.
Publicado: (2023)

Predictors of Preeclampsia in the First Trimester in Normotensive and Chronic Hypertensive Pregnant Women
por: Vázquez, Susana, et al.
Publicado: (2023)

Evaluation of first trimester maternal serum inhibin-A for preeclampsia screening
por: Moungmaithong, Sakita, et al.
Publicado: (2023)

The effect of aspirin on preeclampsia, intrauterine growth restriction and preterm delivery among healthy pregnancies with a history of preeclampsia
por: Abdi, Nazanin, et al.
Publicado: (2020)

Aspirin and Preeclampsia Prevention in Patients With Abnormal Uterine Artery Blood Flow
por: Talari, Hamidreza, et al.
Publicado: (2014)

The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta
por: Walsh, Scott W., et al.
Publicado: (2021)

Aspirin in the prevention of preeclampsia: A protocol for systematic review and meta analysis
por: Mkhize, P.Z., et al.
Publicado: (2021)

Bioactive lipid mediators in plasma are predictors of preeclampsia irrespective of aspirin therapy
por: Stephenson, Daniel J., et al.
Publicado: (2023)

Evaluation of impacts of aspirin therapy versus placebo on preeclampsia: An observational study()
por: Zhou, Liping, et al.
Publicado: (2023)

Global Health, Geographical Contingency, and Contingent Geographies
por: Herrick, Clare
Publicado: (2016)

PP13 and PAPP-A in the First and Second Trimesters: Predictive Factors for Preeclampsia?
por: Moslemi Zadeh, Narges, et al.
Publicado: (2012)

Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancy
por: Luque, Ana, et al.
Publicado: (2014)

First-Trimester Serum Acylcarnitine Levels to Predict Preeclampsia: A Metabolomics Approach
por: Koster, Maria P. H., et al.
Publicado: (2015)

Correlation of Maternal Serum Homocysteine in the First Trimester with the Development of Gestational Hypertension and Preeclampsia
por: Sun, Feng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_krkpt1j239n37912kvbl6m5em0